Walleye Capital
GMED icon

Walleye Capital’s Globus Medical GMED Stock Holding History

Walleye Capital’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$529K Sell
6,700
-9,800
-59% -$833K ﹤0.01% 2676
2026
Q1 		$1.42M Buy
16,500
+11,800
+251% +$1.06M 0.01% 1758
2025
Q4 		$410K Buy
+4,700
New +$357K ﹤0.01% 3076
2025
Q1 		– Sell
-1,000
Closed -$82.7K – 4564
2024
Q4 		$82.7K Hold
1,000
– – ﹤0.01% 4210
2024
Q3 		$71.5K Sell
1,000
-13,600
-93% -$960K ﹤0.01% 4528
2024
Q2 		$1,000K Buy
+14,600
New +$872K ﹤0.01% 2851
2024
Q1 		– Sell
-3,200
Closed -$171K – 5571
2023
Q4 		$171K Buy
+3,200
New +$156K ﹤0.01% 3767

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Walleye Capital's GMED Position: Q2 2026 in Review

Walleye Capital increased its Globus Medical (GMED) stake by 579,237% in Q2 2026, buying an estimated $13.3M and bringing the position to 156,421 shares worth $12.4M. The position accounts for 0.04% of the portfolio, ranked #395.

Walleye Capital first reported a position in GMED in Q4 2020 and has held it in 23 quarters since. The position peaked at $71.5M in Q4 2025. 600 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Walleye Capital held 156,421 shares of Globus Medical worth $12.4M as of Q2 2026.
  • Walleye Capital bought 156,394 Globus Medical shares in Q2 2026, an estimated $13.3M.
  • Globus Medical made up 0.04% of Walleye Capital's portfolio in Q2 2026, its #395 holding.
  • Walleye Capital first reported a position in Globus Medical in Q4 2020 and has held it in 23 quarters since.
  • Walleye Capital's Globus Medical position peaked at $71.5M in Q4 2025.
  • 600 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.